Group 2 mycoplasmaviruses are enveloped particles with an average diameter of 80 nm (reviewed in 11). MVL2, an isolate selected for further study, has been found to contain supercoiled circular double-stranded DNA of about 7.8 x 106 daltons (J. A. Nowak and J. Maniloff, manuscript in preparation). MVL2 is the only reported enveloped virus of procaryotes whose infection is nonlytic (14) : this type of infection can occur in mycoplasmas because these are the only procaryotes without cell walls.
In a study of MVL2 growth, viral infection was found to be nonlytic, with newly infected mycoplasma cells growing slower and being more osmotically stable than uninfected cells (14) . Electron micrographs show virus particles budding from the cell membrane (11) . Growth studies showed that, after a period during which progeny viruses increased exponentially, the rate of virus production decreased and a persistent viral infection was established (14) . Persistently infected cells have a growth rate and osmotic fragility indistinguishable from those of uninfected cells and could be maintained by repeated transfers. These cultures contain free virus. After removing free virus by washing, the persistently infected culture was cloned. Most cells gave rise to clones of persistently infected cells; the remainder were thought to be virus resistant.
We report here on studies to further characterize persistent infection by MVL2. These show that mycoplasma cells from a persistently infected culture have the potential to produce infectious virions and are resistant to infection by added MVL2. These properties have been used to defme lysogeny for lytic viral infections (e.g., see 1 and 6) and will be discussed below in terms of the nonlytic type of infection of the enveloped mycoplasmaviruses.
MATERIALS AND METHODS Cells and viruses. Unless otherwise stated, Acholeplasma laidlawii strain JAl was used as the indicator host and for virus propagation, as previously described (14) . In some studies, the host used was A. laidlawii strain M1305/68 (hereafter designated strain 1305), which like strain JAl both restricts and modifies group 2 mycoplasmaviruses (10) .
Two viruses were used in this study: (i) MVL2, a group 2 mycoplasmavirus described previously (14) , and (ii) MVL51, a group 1 mycoplasmavirus (nonlytic bullet-shaped particles containing circular singlestranded DNA with a molecular weight of 1.5 x 106) (J. A. Nowak, J. Maniloff, and J. Das, FEMS Lett., in press).
The establishment of the A. laidlawii JAl culture persistently infected with MVL2 that was used in these studies was described previously (14) . The initial infection of these cells was at a multiplicity of infection (MOI) of 30, and the culture was maintained by daily transfer. Clones of persistently infected cells which had been isolated (described in 14) were also maintained by daily transfer.
Media and growth. Tryptose broth and agar plates (containing 1% glucose and 1% pleuropneumonia-like organism serum fraction) were used for cultivating cells and for viability assays, as described previously (8) . Cells w'ere assayed as colony-forming units PERSISTENT MYCOPLASMAVIRUS INFECTION 255 virus was calculated.
Virus induction. To obtain reproducible induction, the following protocol was established. An overnight culture was diluted with an equal volume of fresh medium, incubated for 30 min at 370C, and then either treated with mitomycin C or irradiated with UV light. Mitomycin C (Sigma Chemical Co., St. Louis, Mo.) was dissolved in tryptose broth medium (1 mg/ml) and added to a culture sample. Cultures were incubated in the dark at 370C for either 10 or 30 min.
A dilution series was then done, and PFU and CFU assays were carried out with the use of the higher dilution tubes (>100-fold dilution): these dilutions reduced the mitomycin C concentration so that it did not affect growth of cell lawns. In cases where it was necessary to assay PFU of undiluted treated cultures, the cells were centrifuged (7,700 x g for 10 min at 4°C) and resuspended in fresh medium, to remove mitomycin C, and were then plated.
For UV studies, cultures were diluted 10-fold with buffer (0.1 M Tris, 0.15 M NaCl, adjusted to pH 7.4), and 10 ml (in a 100-mm petri dish) was irradiated at room temperature in the dark. The culture was continuously agitated during irradiation. The UV source was a Westinghouse germicidal lamp (257 nm) After various UV doses, samples were removed and immediately plated for PFU and CFU. This plating and the subsequent incubation of the plates were done in the dark (3, 4) .
RESULTS
Preliminary considerations. In a previous report (14) , the cloning of an A. laidlawii JAl liquid culture, persistently infected with MVL2, was described. This cloning was done by washing the cells to remove free virus, diluting, and dispensing cells into tubes of fresh medium such that each tube received an average of less than one cell. In the experiment reported previously (14) , 40 As a control, clones of the indicator strain JAl were tested and almost all plaqued both MVL51 and MVL2 JA1 (Table 1X . Three of these 108 clones failed to plaque MVL51; one of these also failed to plaque MVL2 JAl. None of the 40 clones from the persistently infected culture plaqued either MVL2 JAl or MVL2-1305, whereas 36 of the 40 clones plaqued MVL51. Hence, clones from the persistently infected culture seem to be resistant to superinfection by homologous virus, but not by heterologous virus. The question of whether the 5 clones containing no PFU, isolated from the persistently infected culture, arose from spontaneously resistant variants or as a result of the virus infection will be discussed below.
Stability of the infected state. One low-PFU-containing clone (designated clone 11-L), which contained approximately 1 PFU/104 CFU, was recloned to determine whether every cell in clone 11-L had the potential to produce virus. The recloning followed the dilution protocol described above for the original culture persistently infected with MVL2. However, in this case, since the ratio of PFU to CFU was much less than one, it was not necessary to wash to remove free extracellular virus before dilution and dispensing into tubes.
A summary of the recloning results is shown in The 77 clones derived from clone 11-L were tested for their ability to plaque MVL51 and MVL2. Like clone 11-L, all 77 clones were able to plaque MVL51, but none plaqued MVL2 (data not shown).
Of the 77 tubes containing cells, none was found to contain a high PFU titer, 60 had a low-PFU-containing clone, and 17 contained clones which did not have PFU. Therefore, the low PFU phenotype of clone 11-L cannot be due to an equilibrium between virus-producing and virus-nonproducing cells. Because it is a low-PFUcontaining culture, most CFU in clone 11-L do not produce plaques. However, 60 of 77 clones from the clone 11-L culture were found to produce low-PFU-containing cultures. This indicates that most cells in a low-PFU-containing culture have the potential to produce MVL2 virus and that this is a stable heritable trait.
It should be noted that the 17 clones that do not contain PFU represent isolates from clone 11-L which, in turn, was derived from a single cell persistently infected with MVL2. Therefore, these 17 clones are progeny of a cell that had contained the viral genome. Hence, these 17 clones represent cells which no longer produce infectious particles, but retain the resistance to MVL2 which was a consequence of the original viral infection.
Certain clones derived from the original persistently infected culture (described in 14) and from clone 11-L (described in Table 2 ) were selected for further experiments. These are listed in Clones isolated from persistently infected cultures might be resistant to MVL2 infection as a result of an inability of these cells to adsorb virus. To examine this possibility, MVL2 virus was added to various clones, and the number of unadsorbed viruses was measured after a 1 h incubation. Since the adsorption studies must be carried out at a low MOI, clones containing hightiter PFU could not be examined in these experiments, as the high-PFU background of these cultures would obscure added virus. Using four clones (derived from clone 11-L) containing low or no PFU, we found that three clones did not adsorb added MVL2 (Table 4) . However, in one case adsorption was comparable to that found for uninfected cells. Therefore, lack of adsorption may explain most, but not all, of the resistance of these clones to further MVL2 infection.
Since a persistent infection might involve the maintenance of temperature-sensitive viruses, PERSISTENT (Fig. 2) show the instability in PFU titer of a given clone, which retained its low-PFU-containing characteristic during this period and subsequent growth.
Induction of high PFU titers in low-PFU-containing clones (clones 18-L and 34-L) was attempted by use of mitomycin C and UV treatments. These treatments were also used to try to induce PFU in uninfected JAl cells and clone 5-R; the latter was isolated from a low-PFUcontaining clone and no longer contains PFU.
Increasing concentrations of mitomycin C inv duced an increase in PFU in clone 34-L and decreased the CFU (Fig. 3) . Maximal induction was a 2.6-fold increase in PFU at 10 ,ug of mitomycin C/ml, which corresponds to a cell survival fraction of about 10-3. Higher mitomycin C concentrations killed more cells and reduced the number of observed PFU. A shorter (10 min) (Table 6) , whereas it induced a 2.9-fold increase in PFU in clone 34-L in this experiment.
In the experiments presented thus far, cultures were plated immediately after mitomycin C treatment. To examine the release of viruses after induction, clone 18-L was treated for 30 min with 1 jig of mitomycin C/ml (the optimal concentration for clone 18-L), diluted 100-fold with fresh medium to reduce the mitomycin C concentration, and plated for CFU and PFU at various times up to 240 min (Fig. 4) . By 30 min, the time at which mitomycin C was diluted out, nentially. Since mitomycin C-treated cells were not growing during the experiments, the increase in PFU must have been due to induction of viral replication.
UV irradiation of clone 18-L also gave induction. With increasing UV dose (Fig. 5) (7, 16, 17 (6, 12, 13) . However, a viral mutant has been isolated which establishes the first type of persistent infection, with every cell in an infected culture capable of producing infectious particles (6) .
Mycoplasmavirus MVL2 is a nonlytic enveloped budding virus (11, 14) . Among viruses of procaryotes, this type of morphology and maturation is probably only possible for a mycoplasmavirus, since mycoplasmas are bounded only by a cell membrane. This similarity between MVL2 and enveloped budding animal viruses was investigated further in the studies reported here by examining the method of establishment of MVL2 persistent infection.
A culture persistently infected with MVL2 contains several types of cells; on cloning, these give rise to cultures containing either a high PFU titer, a low PFU titer, or no PFU (14) . All three types of clones were found to be resistant to homologous virus infection and sensitive to heterologous virus (Table 1) .
We have reported here further studies of cultures having a low PFU phenotype (i.e., about 1 PFU/104 CFU). Since only 10% of these PFU are free virus (Fig. 2) , the low PFU characteristic of these cultures means that cell growth takes place in the presence of almost no free virus. Cloning these cultures shows that most cells can give rise to low-PFU-containing cultures. The remaining cells are virus resistant. Therefore, cells in a low-PFU-containing persistently infected culture have the potential to produce virus and transmit this potential as a stable heritable trait. Furthermore, the properties of these low-PFU-containing cultures are those of the first type of persistent infection, defined above for noncytocidal enveloped budding animal viruses.
A variation in the number of PFU relative to the number of CFU was noted in the low-PFUcontaining cultures (Fig. 2) , although the culture retained its low PFU characteristic. Similar fluctuations have been reported in lysogenic bacterial cultures (9).
Low-PFU-containing A. laidlawii cultures were started and maintained at 37°C. Since virus assays done at 37'C gave slightly more PFU than those done at 30°C ( (Fig. 3 and 5) . Maximal induction was seen with a mitomycin C treatment that gave at least a 103-fold decrease in CFU and a UV dose that gave a 10-fold CFU decrease. The mitomycin C-or UV-treated cells induced to produce MVL2 might be either the remaining viable CFU or the inactivated cells. The induction of cells persistently infected with MVL2 cannot be directly compared with induction of lysogenic bacteriophages, since the latter measures the induction of a lytic phage burst and the experiments on MCL2 measure the induction of a nonlytic virus. The lack of induction of a clone containing no PFU (Table 6) , which was derived from a low-PFU-containing culture, could mean either that the clone does not contain a classic type of prophage or that some induction condition (e.g., dosage, exposure time, or inducing agent) was not optimal. Another possibility (not examined in these studies) is that induction did occur, but that the product was defective and therefore not detected in the plaque assay used.
In summary, the experiments reported here show that the nonlytic enveloped mycoplasmavirus MVL2 can establish a persistent infection, similar to that described for some noncytocidal enveloped budding animal viruses. In the persistently infected culture described here, only about 1 in 104 cells normally plates as an infectious center. However, cells retain the potential to produce virus as a stable heritable trait, and both mitomycin C and IJV induction increase the number of infectious centers.
